Stay updated with breaking news from James Bradner. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Amgen's new research and development facility in San Francisco. (courtesy photo) Shares of Thousand Oaks-based Amgen gained 12% on May 3, one day after the company disclosed its earnings for the first quarter of 2024 and highlighted the excitement around its weight-loss drug. During the company’s earnings call, Amgen CEO Bob Bradway commented on their
Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market.
Goldman Sachs said Amgen's experimental GLP-1 drug could have peak sales of $5 billion, or 5% of the estimated $100 billion weight loss drug market.
Here is a selection of recent executive hires, promotions and layoffs occurring across the healthcare industry.
Check out this week’s medical marketing news, people on the move and industry chatter.